Voyageur Pharmaceuticals Grants Deferred Share Units

Stock Information for Voyageur Pharmaceuticals Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Voyageur Pharmaceuticals Ltd.

Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch
Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line
Voyageur Clarifies Terms of Previously Announced Agreement
Voyageur Pharmaceuticals Grants Deferred Share Units
Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes
Voyageur Receives $600K Grant from Alberta Innovates for Product Development
Voyageur Secures $687k of Additional Capital from Warrant Exercises
Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.